A kind of sustained-release microsphere preparation of osteocalcin for injection

A slow-release microsphere preparation and osteocalcin technology, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, bone diseases, etc., can solve the problems of easy degradation, difficult purification of extracts, poor stability, etc. problem, to achieve the effect of easy control of process conditions, good safety in vivo, and convenient quality control

Inactive Publication Date: 2011-11-30
JINLIN MEDICAL COLLEGE
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Chinese patent publication CN101674839A (application number 200880014594.4, application date March 5, 2008) discloses a method for extracting osteocalcin and related compositions, which include medicines, feeds, growth promoters and oral care compositions etc., but the composition of the extract is complex and difficult to purify, and the stability of osteocalcin in the pharmaceutical compo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of sustained-release microsphere preparation of osteocalcin for injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Example 1 Preparation of sustained-release microspheres for injection of osteocalcin

[0021] The formula is as follows:

[0022] Osteocalcin 20g

[0023] Zinc carbonate 0.5g

[0024] Lactic acid-glycolic acid copolymer 100g.

[0025] The preparation method is as follows:

[0026] 1) dissolving osteocalcin and zinc sulfate in water, adjusting the pH value to 8-10 with sodium bicarbonate, as the inner water phase;

[0027] 2) dissolving the lactic acid-glycolic acid copolymer in methylene chloride as the oil phase;

[0028] 3) Mix the inner water phase with the oil phase, and stir at 9500 rpm under ice bath conditions to form colostrum;

[0029] 4) under the stirring condition of 9500 rpm, adding colostrum into polyvinyl alcohol aqueous solution with a mass concentration of 4% to obtain double emulsion;

[0030] 5) Stir the double emulsion at room temperature at 9500 rpm for 5 hours, collect the microspheres by centrifugation, wash the microspheres with water for i...

Embodiment 2

[0031] Example 2 Preparation of sustained-release microspheres for injection of osteocalcin

[0032] The formula is as follows:

[0033] Osteocalcin 30g

[0034] Zinc carbonate 0.4g

[0035] Lactic acid-glycolic acid copolymer 100g.

[0036] The preparation method is as follows:

[0037] 1) dissolving osteocalcin and zinc sulfate in water, adjusting the pH value to 8-10 with sodium bicarbonate, as the inner water phase;

[0038] 2) dissolving the lactic acid-glycolic acid copolymer in methylene chloride as the oil phase;

[0039] 3) Mix the inner water phase with the oil phase, and stir at 9500 rpm under ice bath conditions to form colostrum;

[0040] 4) under the stirring condition of 9500 rpm, adding colostrum into polyvinyl alcohol aqueous solution with a mass concentration of 4% to obtain double emulsion;

[0041] 5) Stir the double emulsion at room temperature at 9500 rpm for 5 hours, collect the microspheres by centrifugation, wash the microspheres with water for i...

Embodiment 3

[0042] Embodiment 3 prepares the sustained-release microsphere preparation for injection of osteocalcin

[0043] The formula is as follows:

[0044] Osteocalcin 15g

[0045] Zinc carbonate 0.4g

[0046] Lactic acid-glycolic acid copolymer 100g.

[0047] The preparation method is as follows:

[0048] 1) dissolving osteocalcin and zinc sulfate in water, adjusting the pH value to 8-10 with sodium bicarbonate, as the inner water phase;

[0049] 2) dissolving the lactic acid-glycolic acid copolymer in methylene chloride as the oil phase;

[0050] 3) Mix the inner water phase with the oil phase, and stir at 9500 rpm under ice bath conditions to form colostrum;

[0051] 4) under the stirring condition of 9500 rpm, adding colostrum into polyvinyl alcohol aqueous solution with a mass concentration of 4% to obtain double emulsion;

[0052] 5) Stir the double emulsion at room temperature at 9500 rpm for 5 hours, collect the microspheres by centrifugation, wash the microspheres with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an osteocalcin slow-release microsphere preparation for injection, which comprises osteocalcin, zinc sulfate and lactic acid-glycolic acid copolymer, wherein the weight ratio of the osteocalcin to the zinc sulfate to the lactic acid-glycolic acid copolymer is (5-30):(0.1-1):100. The preparation method of the osteocalcin slow-release microsphere preparation for injection comprises the following steps: 1) dissolving the osteocalcin and the zinc sulfate in water, and using as an in-water phase; 2) dissolving lactic acid-glycolic acid copolymer in dichloromethane, and using as an oil phase; 3) mixing the in-water phase and the oil phase, and stirring to obtain a primary emulsion; 4) adding the primary emulsion into a polyvinyl alcohol water solution while stirring, thus obtaining a compound emulsion; and 5) stirring the compound emulsion at room temperature for 5 hours, centrifuging, collecting microspheres, washing the microspheres with water for injection, and carrying out freeze-drying. The preparation disclosed by the invention has good stability, high drug-loading rate and high in-vivo safety, the envelopment rate can be controlled at 82-95%, and the preparation can not be subjected to degradation, aggregation and conformational change under accelerated test conditions. The tail intravenous injection to mice shows that the bioavailability of the slow-release microsphere preparation for injection can be up to 72-76%.

Description

technical field [0001] The invention relates to a pharmaceutical preparation of osteocalcin, in particular to a sustained-release microsphere preparation of osteocalcin for injection. Background technique [0002] Osteocalcin, also known as Bone-γ-caboxyglutamic acid containing protein (BGP) or Bone vitamin K depengt protein, is a non-proliferative osteoblast specifically synthesized and secreted. Collagen. [0003] In the past, it was believed that osteocalcin was closely related to osteoporosis, and its main function was to maintain the normal mineralization of bone and inhibit the activity of osteoblasts, leading to osteoporosis. Recent studies have shown that osteocalcin has a therapeutic effect on diabetes. The research and development of osteocalcin-related pharmacology and pharmaceutical preparations has become one of the hot spots in pharmaceutical research and development. [0004] Chinese patent publication CN101674839A (application number 200880014594.4, applic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/16A61K38/17A61K47/34A61P3/10A61P19/08
Inventor 王会岩厉保秋高继友蔡建辉李艳
Owner JINLIN MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products